The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
How X-Rays Are Absorbed By Matter
An X-ray beam can ionize matter in just a few hundred femtoseconds, researchers say.
10 Medical Devices That Changed The World
Medical devices may sound like a modern invention, but they in fact have helped us manage and treat diseases for centuries. Here are our top ten picks of medical gadgets that play a significant role in our lives, many of them so ubiquitous that we sometimes take them for granted.
WuXi To Offer Foundation’s Genomic Profiling In China
WuXi has been licensed to perform the FoundationOne® assay, providing the best-in-class genomics platform to biopharmaceuticals in China.
Enhanced Genomics Services For Chinese Researchers
WuXi's customers can look forward to enhanced sequence analysis capabilities thanks to a partnership with NextCODE Health.
WuXi To Build Third Cell Therapy Facility
The company's third cell therapy manufacturing facility will focus on chimeric antigen receptor T cells for cancer immunotherapy.
WuXi NextCODE Selected To Run 100,000 Genomes Project
WuXi NextCODE has been appointed to carry out the first phase of an ambitious project to sequence 100,000 genomes in the UK.
AstraZeneca Expands Presence in Asia With Deals in China and Japan
AstraZeneca has entered a strategic alliance with WuXi AppTech and acquired Takeda's respiratory business.
The Cells That Enable Zebrafish To Regenerate Bone
Scientists in Japan have identified a group of progenitor cells that are maintained throughout adulthood and are responsible for bone regeneration.
CiRA & Takeda Announce Joint iPS Cell Research
Takeda, Japan's largest pharmaceutical company, will provide US$166 million of funding for iPS research over the next ten years.